News Choose Year All Years 2026 (5) 2025 (6) 2024 (6) 2023 (2) 2022 (2) 2021 (1) Search Press Releases Found 22 Results October 22, 2026 Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases Read More August 27, 2026 Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting Read More July 15, 2026 Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman Read More May 27, 2026 Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis Read More May 13, 2026 Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026 Read More December 22, 2025 Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease Read More June 6, 2025 Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025 Read More May 21, 2025 Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025 Read More 123»
Read More